Filter

Refine by Access

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 1 - 7 of 7 items for

  • Author or Editor: A P Durbin x
  • Refine by Access: All content x
Clear All Modify Search

A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.

J M Troyer, K A Hanley, S S Whitehead, D Strickman, R A Karron, A P Durbin, and B R Murphy
Volume/Issue:
Volume 65: Issue 5
DOI:
https://doi.org/10.4269/ajtmh.2001.65.414
Publication Date:
01 Nov 2001
Full access

Antigenic Relationships between Sylvatic and Endemic Dengue Viruses

Nikos Vasilakis, Anna P. Durbin, Amelia P. A. Travassos da Rosa, Jorge L. Munoz-Jordan, Robert B. Tesh, and Scott C. Weaver
Volume/Issue:
Volume 79: Issue 1
DOI:
https://doi.org/10.4269/ajtmh.2008.79.128
Publication Date:
01 Jul 2008
Full access

Decay and Persistence of Maternal Dengue Antibodies among Infants in Bangkok

Willem G. van Panhuis, Christine Luxemburger, Krisana Pengsaa, Kriengsak Limkittikul, Arunee Sabchareon, Jean Lang, Anna P. Durbin, and Derek A. T. Cummings
Volume/Issue:
Volume 85: Issue 2
DOI:
https://doi.org/10.4269/ajtmh.2011.11-0125
Publication Date:
01 Aug 2011
Full access

Phase I Clinical Evaluation of rDEN4Δ30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity

Julie H. McArthur, Anna P. Durbin, Jennifer A. Marron, Kimberli A. Wanionek, Bhavin Thumar, Dennis J. Pierro, Alexander C. Schmidt, Joseph E. Blaney Jr, Brian R. Murphy, and Stephen S. Whitehead
Volume/Issue:
Volume 79: Issue 5
DOI:
https://doi.org/10.4269/ajtmh.2008.79.678
Publication Date:
01 Nov 2008
Full access

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

A P Durbin, R A Karron, W Sun, D W Vaughn, M J Reynolds, J R Perreault, B Thumar, R Men, C J Lai, W R Elkins, R M Chanock, B R Murphy, and S S Whitehead
Volume/Issue:
Volume 65: Issue 5
DOI:
https://doi.org/10.4269/ajtmh.2001.65.405
Publication Date:
01 Nov 2001
Full access

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers

Peter F. Wright, Anna P. Durbin, Stephen S. Whitehead, Mine R. Ikizler, Susan Henderson, Joseph E. Blaney, Bhavin Thumar, Sharon Ankrah, Michael T. Rock, Brett A. McKinney, Brian R. Murphy, and Alexander C. Schmidt
Volume/Issue:
Volume 81: Issue 5
DOI:
https://doi.org/10.4269/ajtmh.2009.09-0131
Publication Date:
01 Nov 2009
Full access

Comparing the Understanding of Subjects Receiving a Candidate Malaria Vaccine in the United States and Mali

Ruth D. Ellis, Issaka Sagara, Anna Durbin, Alassane Dicko, Donna Shaffer, Louis Miller, Mahamadoun H. Assadou, Mamady Kone, Beh Kamate, Ousmane Guindo, Michael P. Fay, Dapa A. Diallo, Ogobara K. Doumbo, Ezekiel J. Emanuel, and Joseph Millum
Volume/Issue:
Volume 83: Issue 4
DOI:
https://doi.org/10.4269/ajtmh.2010.10-0062
Publication Date:
05 Oct 2010
Full access